Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michael Leibowitz

Concepts (128)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
6
2013
427
0.930
Why?
Carcinoma, Squamous Cell
5
2013
577
0.830
Why?
Hamartoma Syndrome, Multiple
1
2022
12
0.790
Why?
Hemangiosarcoma
1
2022
18
0.780
Why?
STAT1 Transcription Factor
2
2013
63
0.770
Why?
Neuroblastoma
1
2022
133
0.730
Why?
Skin Neoplasms
1
2022
754
0.470
Why?
T-Lymphocytes, Cytotoxic
2
2013
154
0.450
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 11
1
2013
20
0.420
Why?
Tumor Escape
2
2019
35
0.400
Why?
HLA Antigens
1
2013
220
0.380
Why?
ATP-Binding Cassette Transporters
1
2011
122
0.340
Why?
Immunotherapy
2
2009
473
0.290
Why?
Interleukin-6
1
2008
673
0.230
Why?
Antigen Presentation
3
2011
188
0.220
Why?
Cancer Vaccines
3
2009
137
0.210
Why?
CD8-Positive T-Lymphocytes
3
2019
686
0.200
Why?
PTEN Phosphohydrolase
1
2022
140
0.180
Why?
NAD
1
2020
63
0.180
Why?
Endomyocardial Fibrosis
1
2019
3
0.170
Why?
RNA, Small Interfering
2
2013
534
0.170
Why?
Lactic Acid
1
2020
272
0.160
Why?
Cell Line, Tumor
4
2019
2700
0.160
Why?
Interleukin-12
1
2019
110
0.160
Why?
Calcineurin
1
2019
89
0.150
Why?
Biomarkers
1
2008
3397
0.150
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2019
64
0.150
Why?
STAT3 Transcription Factor
2
2011
172
0.150
Why?
Fibroblasts
2
2019
834
0.150
Why?
Immunotherapy, Adoptive
1
2019
184
0.140
Why?
Fibrosis
1
2019
452
0.140
Why?
Transforming Growth Factor beta
1
2019
445
0.130
Why?
Carcinoma
2
2011
198
0.130
Why?
Peptides
3
2009
847
0.120
Why?
Cytokines
3
2019
1824
0.100
Why?
Cell Differentiation
1
2019
1696
0.100
Why?
Interferon-gamma
2
2013
719
0.100
Why?
Keratinocytes
1
2013
215
0.090
Why?
Neoplasms, Squamous Cell
1
2011
4
0.090
Why?
Chromatin Immunoprecipitation
1
2011
128
0.090
Why?
Immunoprecipitation
1
2011
151
0.090
Why?
Down-Regulation
1
2013
594
0.090
Why?
Immunoblotting
1
2011
282
0.090
Why?
T-Lymphocytes
2
2008
1735
0.090
Why?
Humans
13
2022
114050
0.090
Why?
Receptor, EphA2
1
2008
19
0.080
Why?
Phosphorylation
1
2013
1558
0.080
Why?
Antigen-Presenting Cells
1
2008
150
0.070
Why?
Epitopes, T-Lymphocyte
1
2008
170
0.070
Why?
Gene Expression Regulation, Neoplastic
1
2013
1145
0.070
Why?
Oligonucleotides
1
2008
137
0.070
Why?
Promoter Regions, Genetic
1
2011
1131
0.070
Why?
Neoplasm Proteins
1
2008
385
0.060
Why?
Recurrence
1
2008
925
0.060
Why?
Telomerase
1
2007
204
0.060
Why?
Pleural Effusion, Malignant
1
2005
8
0.060
Why?
Cell Survival
1
2008
1014
0.060
Why?
Mesothelioma
1
2005
31
0.060
Why?
Tumor Suppressor Protein p53
1
2007
445
0.060
Why?
Gene Expression
1
2008
1417
0.050
Why?
Child
1
2022
18404
0.050
Why?
T-Lymphocytes, Regulatory
1
2005
337
0.050
Why?
Prostatic Neoplasms
1
2008
913
0.050
Why?
Models, Biological
1
2008
1611
0.050
Why?
Mice, Inbred C57BL
2
2019
4681
0.040
Why?
Vaccination
1
2007
1202
0.040
Why?
Ovalbumin
1
2019
161
0.040
Why?
Antigens, Surface
1
2019
146
0.040
Why?
Breast Neoplasms
2
2007
1846
0.040
Why?
CD4-Positive T-Lymphocytes
2
2019
959
0.040
Why?
Antibodies, Neoplasm
2
2008
30
0.040
Why?
Transforming Growth Factor beta1
1
2019
153
0.040
Why?
Gene Knockdown Techniques
1
2019
301
0.040
Why?
Signal Transduction
1
2011
4501
0.040
Why?
Animals
5
2019
31567
0.040
Why?
Myofibroblasts
1
2019
115
0.040
Why?
Treatment Outcome
2
2009
9049
0.040
Why?
Bleomycin
1
2019
228
0.040
Why?
Oxidation-Reduction
1
2020
917
0.040
Why?
Wound Healing
1
2019
254
0.040
Why?
Antineoplastic Agents
1
2008
1875
0.040
Why?
Collagen
1
2019
414
0.030
Why?
Mice
3
2019
14845
0.030
Why?
Lymphocyte Activation
1
2019
1036
0.030
Why?
Mice, Transgenic
1
2019
1947
0.030
Why?
Cell Proliferation
1
2020
2173
0.030
Why?
Idiopathic Pulmonary Fibrosis
1
2019
500
0.030
Why?
Antibodies, Monoclonal
2
2009
1257
0.030
Why?
Disease Progression
1
2019
2371
0.030
Why?
Vaccines, DNA
1
2009
29
0.020
Why?
Receptors, Growth Factor
1
2009
49
0.020
Why?
No-Observed-Adverse-Effect Level
1
2008
5
0.020
Why?
bcl-X Protein
1
2008
38
0.020
Why?
Macaca fascicularis
1
2008
50
0.020
Why?
Toxicity Tests
1
2008
28
0.020
Why?
Cyclin D1
1
2008
61
0.020
Why?
Neoplasm Transplantation
1
2008
227
0.020
Why?
Proteasome Endopeptidase Complex
1
2008
133
0.020
Why?
Adoptive Transfer
1
2008
194
0.020
Why?
Injections, Intramuscular
1
2008
117
0.020
Why?
Mice, SCID
1
2008
312
0.020
Why?
Epitopes, B-Lymphocyte
1
2007
16
0.020
Why?
Interleukin-5
1
2007
30
0.020
Why?
Tubulin
1
2008
122
0.020
Why?
Immunologic Factors
1
2009
217
0.020
Why?
HLA-DQ Antigens
1
2007
174
0.020
Why?
Lung
1
2019
3521
0.020
Why?
Lymphocytes, Tumor-Infiltrating
1
2007
111
0.020
Why?
Cytomegalovirus
1
2007
143
0.020
Why?
Th2 Cells
1
2007
154
0.020
Why?
HLA-DR Antigens
1
2007
219
0.020
Why?
Neoplasm Metastasis
1
2008
521
0.020
Why?
Protein Structure, Tertiary
1
2008
796
0.020
Why?
Dendritic Cells
1
2009
435
0.020
Why?
Female
4
2019
59328
0.020
Why?
Leukocytes, Mononuclear
1
2007
489
0.020
Why?
Receptors, Interleukin-2
1
2005
64
0.020
Why?
CD4 Antigens
1
2005
123
0.010
Why?
Polymorphism, Genetic
1
2007
610
0.010
Why?
Amino Acid Sequence
1
2007
1981
0.010
Why?
Male
3
2019
55400
0.010
Why?
Molecular Sequence Data
1
2007
2783
0.010
Why?
Disease Models, Animal
1
2008
3498
0.010
Why?
Carcinoma, Non-Small-Cell Lung
1
2005
959
0.010
Why?
Lung Neoplasms
1
2005
2159
0.010
Why?
Aged
1
2007
18971
0.010
Why?
Middle Aged
1
2007
26607
0.000
Why?
Adult
1
2007
30377
0.000
Why?
Leibowitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)